Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 2
1980 5
1981 1
1982 3
1983 3
1984 1
1985 2
1988 2
1989 3
1990 2
1991 2
1992 3
1993 1
1998 1
2000 2
2002 1
2004 1
2005 2
2006 3
2007 4
2008 2
2009 2
2010 3
2011 3
2012 9
2013 6
2014 6
2015 5
2016 4
2017 9
2018 2
2019 8
2020 3
2021 3
2022 4
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.
DiPeri TP, Evans KW, Raso MG, Zhao M, Rizvi YQ, Zheng X, Wang B, Kirby BP, Kong K, Kahle M, Yap TA, Dumbrava EE, Ajani JA, Fu S, Keyomarsi K, Meric-Bernstam F. DiPeri TP, et al. Among authors: kahle m. Clin Cancer Res. 2023 Nov 1;29(21):4385-4398. doi: 10.1158/1078-0432.CCR-23-0103. Clin Cancer Res. 2023. PMID: 37279095 Free PMC article.
Dupuytren's contracture.
Benson LS, Williams CS, Kahle M. Benson LS, et al. Among authors: kahle m. J Am Acad Orthop Surg. 1998 Jan-Feb;6(1):24-35. doi: 10.5435/00124635-199801000-00003. J Am Acad Orthop Surg. 1998. PMID: 9692938 Review.
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.
DiPeri TP, Zhao M, Evans KW, Varadarajan K, Moss T, Scott S, Kahle MP, Byrnes CC, Chen H, Lee SS, Halim AB, Hirai H, Wacheck V, Kwong LN, Rodon J, Javle M, Meric-Bernstam F. DiPeri TP, et al. Among authors: kahle mp. J Hepatol. 2024 Feb;80(2):322-334. doi: 10.1016/j.jhep.2023.10.041. Epub 2023 Nov 14. J Hepatol. 2024. PMID: 37972659
Precision Oncology: Evolving Clinical Trials across Tumor Types.
Song IW, Vo HH, Chen YS, Baysal MA, Kahle M, Johnson A, Tsimberidou AM. Song IW, et al. Among authors: kahle m. Cancers (Basel). 2023 Mar 25;15(7):1967. doi: 10.3390/cancers15071967. Cancers (Basel). 2023. PMID: 37046628 Free PMC article.
OCTANE: Oncology Clinical Trial Annotation Engine.
Zeng J, Shufean MA, Khotskaya Y, Yang D, Kahle M, Johnson A, Holla V, Sánchez N, Mills Shaw KR, Bernstam EV, Meric-Bernstam F. Zeng J, et al. Among authors: kahle m. JCO Clin Cancer Inform. 2019 Jul;3:1-11. doi: 10.1200/CCI.18.00145. JCO Clin Cancer Inform. 2019. PMID: 31265323 Free PMC article.
Actin complexes in the cell nucleus: new stones in an old field.
Castano E, Philimonenko VV, Kahle M, Fukalová J, Kalendová A, Yildirim S, Dzijak R, Dingová-Krásna H, Hozák P. Castano E, et al. Among authors: kahle m. Histochem Cell Biol. 2010 Jun;133(6):607-26. doi: 10.1007/s00418-010-0701-2. Epub 2010 May 5. Histochem Cell Biol. 2010. PMID: 20443021 Review.
111 results